Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
XYS-NEURO PEDIATRIE from Rixensart, company number BE0886107272, closed financial year 2024 with a result of € -27,221 after tax. For that financial year XYS-NEURO PEDIATRIE recorded a gross margin of € 38,183 and equity of € 128,742. Compared with financial year 2023, the result moved from € 80,796 to € -27,221. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2025.
€ 128,742
▼ 17% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,221
▼ still € 80,796 profit in 2023
Profit after tax over the fiscal year.
€ 28,383
▼ 64% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 116,342.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 92,315
▼ 38% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 42,924
▼ 29% vs 2023
€ 16,920 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 4,434
▲ € 4,381 vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 50,580
▼ 34% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 342 | € 91,052 | € 177,968 | € 38,183 | ▼ 79% |
| Profit after taxes | € -3,928 | € 57,275 | € 80,796 | € -27,221 | ▼ € 108,018 |
| Equity | € 17,892 | € 75,167 | € 155,963 | € 128,742 | ▼ 17% |
| Total debts | € 9,700 | € 100,342 | € 190,966 | € 121,214 | ▼ 37% |
| Cash | € 6,705 | € 29,967 | € 78,605 | € 28,383 | ▼ 64% |
| Retained profit | € 5,492 | € 62,767 | € 143,563 | € 116,342 | ▼ 19% |
| Bank debt | € 0 | € 79,495 | € 60,248 | € 42,924 | ▼ 29% |
| Balance sheet total | € 27,591 | € 175,508 | € 346,929 | € 249,955 | ▼ 28% |
Key figures of XYS-NEURO PEDIATRIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to XYS-NEURO PEDIATRIE?
What happened at XYS-NEURO PEDIATRIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 27,221 (▼ € 108,018 vs 2023). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Rixensart. KBO
- XAVIER SCHLOGEL became a director. NBB
In short
From € 3,928 loss in 2021 to € 27,221 loss in 2024.
Paid € 64,571 in corporate taxes since 2021.
Best year ever: 2023, with € 80,796 profit.
A new publication or filing at XYS-NEURO PEDIATRIE? We notify you, reason included.
Follow XYS-NEURO PEDIATRIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind XYS-NEURO PEDIATRIE is XAVIER SCHLOGEL.
Directors
According to the 2024 annual accounts
XAVIER SCHLOGEL
Director
since 2006
Establishments
Establishment units
Physical locations of this company
Avenue Paul Terlinden 2 box 2
1330 Rixensart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0886.107.272
- VAT number
- BE 0886.107.272
- Registered office
- Avenue Paul Terlinden 2 bus 2, 1330 Rixensart
- Names & denominations
- XYS-NEURO PEDIATRIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2007
- Peppol
- Not registered